Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Rheumatology (Oxford, England)|October 29, 2025
Risk of hospitalisation with pneumonia in patients with giant cell arteritis and anti-neutrophil cytoplasmic antibody associated vasculitisMads E R Sørensen, René Cordtz, Kirsten S Duch, et al.
Rheumatology (Oxford, England)|December 28, 2020
Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from DenmarkRené Cordtz, Jesper Lindhardsen, Bolette G Soussi, et al.
Rheumatology (Oxford, England)|July 7, 2023
Temporal trends in mortality in patients with rheumatoid arthritis: a Danish population-based matched cohort studyBolette G Soussi, Kirsten Duch, René L Cordtz, et al.
Arthritis and Rheumatism|February 1, 2011
Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registryBente Glintborg, Mikkel Østergaard, Lene Dreyer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2019
Comparative Effectiveness of Certolizumab Pegol, Abatacept, and Biosimilar Infliximab in Patients With Rheumatoid Arthritis Treated in Routine Care: Observational Data From the Danish DANBIO Registry Emulating a Randomized TrialKathrine L Grøn, Bente Glintborg, Mette Nørgaard, et al.
Rheumatology (Oxford, England)|August 12, 2020
Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based studyElse Helene Ibfelt, Rikke Kart Jacobsen, Tine Iskov Kopp, et al.
Rheumatology (Oxford, England)|August 30, 2023
Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: a Danish population-based cohort studyRebekka L Hansen, Tanja S Jørgensen, Alexander Egeberg, et al.
The Journal of Rheumatology|February 1, 2024
Polyautoimmunity in Patients With Anticyclic Citrullinated Peptide Antibody-Positive and -Negative Rheumatoid Arthritis: a Nationwide Cohort Study From DenmarkSalome Kristensen, Amalie M Hagelskjær, René Cordtz, et al.
Rheumatology (Oxford, England)|September 15, 2023
Tolerability and comparative effectiveness of TNF, IL-17 and IL-23(p19) inhibitors in psoriatic arthritis: a target trial emulation studyZara R Stisen, Sabrina M Nielsen, Marie Skougaard, et al.
Annals of the Rheumatic Diseases|May 6, 2016
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registersKarin Hellgren, Lene Dreyer, Elizabeth V Arkema, et al.
Pageof 13